PET/MRI, CT metrics assess pathologic response of pancreas cancer to neoadjuvant therapy

Leesburg, VA, December 9, 2020–According to an open-access Editor’s Choice article in ARRS’ American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA). “Imaging metrics associated with pathologic response and overall…